House updates controlled‑substances licensing language, adopts amendment on medically managed treatment

The House passed House Bill 12‑14, a sunset continuation and modernization of the state's Controlled Substances Act licensing framework, and approved an amendment (L001) that updates statutory language to reference "medically managed treatment" and to modernize references to opioid treatment programs.

Sponsor Representative Jackson described the change as "providing updates to definition and changing the words to make it more modernized," and said the amendment ensures the statute accommodates medication‑assisted treatment and a broader continuum of care. "Medically managed treatment means a program of care designed to promote the medical and psychiatric stability of an individual... which may range from short term stabilization to long term medication management," the sponsor read from the amendment language.

Members raised concerns about unintended stigma around opioid prescribing and about legislative oversight of sunset timelines. Representative Johnson moved an amendment to shorten the sunset review from 2041 to 2033, arguing that shorter review timelines preserve legislative oversight; that amendment failed. Sponsors emphasized the bill's limited scope to licensing and compliance with federal requirements necessary to maintain opioid‑treatment program operations.

The measure, as amended, passed on the floor following the machine vote sequence recorded in the session.

Next steps: the bill proceeds for any remaining enactment steps and the department will continue to provide oversight and yearly updates, per committee discussion.